Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

BCR-ABL1 Levels at First Month after TKI Discontinuation Predict Subsequent Maintenance of Treatment-Free Remission: A Study from the "Gruppo Triveneto LMC"

Sara Di Giusto, PhD, Eleonora Toffoletti, MD, Massimiliano Bonifacio, MD, Gianni Binotto, MD, Maria Cristina Miggiano, MD, Elisabetta Calistri, MD, Manuela Stulle, MD, Anna Ermacora, MD, Rossella Stella, MD, Luigi Scaffidi, MD, Fabio D'Amore, MD, Giorgia Scotton, MD, Giovanna De Matteis, PhD, Roberta Bertorelle, PhD, Renato Fanin, MD, Mauro Krampera, MD PhD, Gianpietro Semenzato, MD, Daniela Damiani, MD, Mario Tiribelli, MD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-135968

Published: 2020

Journal Articles

Comparative Monitoring of Minimal Residual Disease (MRD) By RT-Quantitative (RT-qPCR) and Digital PCR (dPCR) in Ph+ Chronic Myeloid Leukemia (CML) Patients Treated with TKIs for Recognition of Stable Deep Molecular Response (DMR) and Identification of Best Candidates to TKIs Treatment Discontinuation

Blood (2018) 132 (Supplement 1): 3012.

https://doi.org/10.1182/blood-2018-99-112391

Published: 2018

Journal Articles

ABCG2 but Not ABCB1 RNA Levels at Diagnosis and during Treatment Correlates with Response to Imatinib and 2G-Tkis Front-Line Therapy in Chronic Phase CML Patients

Mario Tiribelli, MD, Sara Di Giusto, Eleonora Toffoletti, Davide Griguolo, Domenico Penna, Giorgia Maccari, Marta Medeot, Renato Fanin, Daniela Damiani

Blood (2017) 130 (Supplement 1): 1614.

https://doi.org/10.1182/blood.V130.Suppl_1.1614.1614

Published: 2017

Journal Articles

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations

Blood (2015) 125 (4): 600–605.

https://doi.org/10.1182/blood-2014-05-576157

Published: 2015

Includes: Supplemental data

Journal Articles

Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Results of the Unit Study

Francesco Zaja, Elena Boggio, Davide Rossi, MD PhD, Casimiro L. Gigliotti, Eleonora Toffoletti, Giuseppe Cappellano, Orilieri Elisabetta, Simona Puglisi, Monia Lunghi, Nicola Vianelli, MD, Silvia Cantoni, Alessia Tieghi, Eloise Beggiato, Gianluca Gaidano, Miriam Isola, Renato Fanin, Umberto Dianzani

Blood (2014) 124 (21): 1461.

https://doi.org/10.1182/blood.V124.21.1461.1461

Published: 2014

Journal Articles

High-Sensitivity Hematopoietic Chimerism By qPCR For Relapse Prediction and Specific Identification Of HLA Loss Leukemic Variants

Luca Vago, MD, PhD, Benedetta Mazzi, BSc, Lorenza Chiesa, BSc, Raffaella Greco, MD, Cinzia Pultrone, MSc, Eleonora Toffoletti, MD, Cristina Toffalori, PhD, Pietro Crivello, PhD, Veronica Tettamanzi, MSc, Lara Crucitti, MD, Maria Teresa Lupo Stanghellini, MD, Andrea Assanelli, MD, Consuelo Corti, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Chiara Bonini, MD, Douglas A. Bost, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD

Blood (2013) 122 (21): 3313.

https://doi.org/10.1182/blood.V122.21.3313.3313

Published: 2013

Journal Articles

Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Preliminary Results of the Unit Study.

Francesco Zaia, Elena Boggio, Davide Rossi, Eleonora Toffoletti, Giuseppe Cappellano, Elisabetta Orilieri, Simona Puglisi, Monia Lunghi, Nicola Vianelli, Silvia Cantoni, Alessia Tieghi, Eloise Beggiato, Gianluca Gaidano, Renato Fanin, Umberto Dianzani

Blood (2012) 120 (21): 2192.

https://doi.org/10.1182/blood.V120.21.2192.2192

Published: 2012

Journal Articles

Clonality and Phenotype in Spleens From Patients with Primary Immune Thrombocytopenia,

Elena Sabattini, Sr., MD, Pier Paolo Piccaluga, Sr., MD, PhD, Claudia Mannu, BS, Anna Candoni, Anna Gazzola, Carlo Sagramoso, Eleonora Toffoletti, Nicola Vianelli, MD, Nicola Polverelli, MD, Stefano Pileri, MD, Carla Di Loreto, Sr., MD. Prof, Stefano Pizzolitto, Sr., MD, Francesco Zaja, MD

Blood (2011) 118 (21): 3291.

https://doi.org/10.1182/blood.V118.21.3291.3291

Published: 2011

Journal Articles

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

Blood (2010) 116 (21): 967.

https://doi.org/10.1182/blood.V116.21.967.967

Published: 2010

Journal Articles

Q141K Polymorphism of ABCG2 Protein Is Associated with Poor Prognosis In Adult Acute Myeloid Leukemia Treated with a Idarubicin-Based Chemotherapy Protocol

Daniela Damiani, Mario Tiribelli, Angela Michelutti, Dora Fabbro, Alessandra Franzoni, Margherita Cavallin, Antonella Geromin, Eleonora Toffoletti, Annalisa Pianta, Roberto Gallina, Giuseppe Damante, Renato Fanin

Blood (2010) 116 (21): 4941.

https://doi.org/10.1182/blood.V116.21.4941.4941

Published: 2010

Journal Articles

Gemtuzumab-Ozogamicin in Combination with Fludarabine, Cytarabine, Idarubicin (FLAI-GO) as Induction Therapy in CD33-Positive AML patients Younger Than 65 Years. Report of a Multicentric Trial

Blood (2008) 112 (11): 3998.

https://doi.org/10.1182/blood.V112.11.3998.3998

Published: 2008

Journal Articles

Brain Natriuretic Peptide (BNP) Level as Marker of Cardiac Function in Imatinib - Treated Chronic Myeloid Leukemia Patients: No Evidence of Cardiotoxicity of Imatinib Therapy.

Mario Tiribelli, MD, Antonio Colatutto, MD, Luciana Marin, MD, Eleonora Toffoletti, MD, Giuseppe Barbina, PhD, Ugo Qualizza, MD, Elio Tonutti, MD, Anna Candoni, MD, Marta Medeot, MD, Daniela Damiani, MD, Giorgio Morocutti, MD, Sala Pierguido, MD, Renato Fanin, MD

Blood (2007) 110 (11): 2948.

https://doi.org/10.1182/blood.V110.11.2948.2948

Published: 2007

NARROW

BCR-ABL1 Levels at First Month after TKI Discontinuation Predict Subsequent Maintenance of Treatment-Free Remission: A Study from the "Gruppo Triveneto LMC"

ABCG2 but Not ABCB1 RNA Levels at Diagnosis and during Treatment Correlates with Response to Imatinib and 2G-Tkis Front-Line Therapy in Chronic Phase CML Patients

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations

Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Results of the Unit Study

High-Sensitivity Hematopoietic Chimerism By qPCR For Relapse Prediction and Specific Identification Of HLA Loss Leukemic Variants

Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Preliminary Results of the Unit Study.

Clonality and Phenotype in Spleens From Patients with Primary Immune Thrombocytopenia,

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

Q141K Polymorphism of ABCG2 Protein Is Associated with Poor Prognosis In Adult Acute Myeloid Leukemia Treated with a Idarubicin-Based Chemotherapy Protocol

Gemtuzumab-Ozogamicin in Combination with Fludarabine, Cytarabine, Idarubicin (FLAI-GO) as Induction Therapy in CD33-Positive AML patients Younger Than 65 Years. Report of a Multicentric Trial

Brain Natriuretic Peptide (BNP) Level as Marker of Cardiac Function in Imatinib - Treated Chronic Myeloid Leukemia Patients: No Evidence of Cardiotoxicity of Imatinib Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only